Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06955208 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

3D MRE-Based Evaluation of Meningioma Mechanical Properties and Histological Features

StatusRecruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated February 12, 2026 (before its estimated October 9, 2026 completion). Its status may not reflect the trial's current state.

Record History

  1. Primary completion date: Oct 9, 2025 to Oct 9, 2026
    • Study completion date: Oct 9, 2026 to Oct 9, 2027
    v2
  2. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
This prospective single-center study aims to evaluate the feasibility and clinical utility of three-dimensional magnetic resonance elastography (3D MRE) in assessing tumor stiffness and adhesion in patients with meningioma undergoing surgical resection. By correlating preoperative MRE-derived stiffness and adhesion maps with intraoperative findings and histopathological features, the study seeks to determine whether MRE can serve as a noninvasive imaging biomarker for surgical planning, risk stratification, and prediction of tumor behavior.
Trial Details
NCT Number NCT06955208
Lead Sponsor Shengjing Hospital
Conditions
(from sponsor)		 Meningioma
Related terms Meningioma, Tissue Adhesions
Enrollment 300 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov